Lpoxy Therapeutics, Inc.
USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Y (Enzymes).
The verdict
According to USPTO PatentsView, Lpoxy ranks #29,324 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 5 technology areas.
- #29,324
- of 49,997 US assignees by volume
- Top 21%
- by Innovation Score (46.3/100)
- 17.4
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R29324 · US Corporation #29,324 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 9 grants
- MID-PACK #29,324/49,997
- PHOTO-FINISH Loesch Verpackungste…
- CPC-NARROW C12Y · 5 areas
- INNOV-PAR 46.3/100
- CLAIMS-RICH 17.4 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2024–2025 · 2y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Loesch Verpackungstechnik GMBH + Co. KG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Lpoxy’s 46.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Lpoxy
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Lpoxy Therapeutics · this assignee
Lpoxy Therapeutics · this assignee
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Lpoxy's Innovation Score is 46.3/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Lpoxy?
Each dot is one of Lpoxy’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lpoxy’s own 17.4 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Lpoxy's grants concentrate
Lpoxy Therapeutics, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C12Y (Enzymes). By volume, Lpoxy sits between Loesch Verpackungstechnik GMBH + Co. KG and Lucca Ventures, Inc..
Lpoxy's three-year grant acceleration
Lpoxy Therapeutics, Inc. shows 7 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Lpoxy's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Loesch Verpackung…
Loesch Verpackungstechnik GMBH + Co. KG
9 patents
- Lonza Sales
Lonza Sales AG
9 patents
- Look Cycle Intern…
Look Cycle International
9 patents
- Loro Piana S P A
Loro Piana S.P.A.
9 patents
- Lsip
Lsip, LLC
9 patents
- LTA
LTA Corporation
9 patents
- LTN Servotechnik
LTN Servotechnik GmbH
9 patents
- Lucca Ventures
Lucca Ventures, Inc.
9 patents
- Lpoxy Therapeutics ◀
Lpoxy Therapeutics, Inc.
9 patents
What this shows Lpoxy holds 9 patents at rank #29,261, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Lpoxy
By rank, the assignees closest to #29,261 in granted patent volume.
- Loesch Verpackungstechnik GMBH + Co. KG #29,257 · 9 patents
- Lonza Sales AG #29,258 · 9 patents
- Look Cycle International #29,259 · 9 patents
- Loro Piana S.P.A. #29,260 · 9 patents
- Lsip, LLC #29,262 · 9 patents
- LTA Corporation #29,263 · 9 patents
- LTN Servotechnik GmbH #29,264 · 9 patents
- Lucca Ventures, Inc. #29,265 · 9 patents
Leaders in C12Y (Enzymes)
Other assignees with the most granted patents in Lpoxy's primary technology class.
Lpoxy's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 21% higher than 79% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 7 | 77.8% |
| 2025partial year | 2 | 22.2% |
Which technologies does Lpoxy Therapeutics, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Lpoxy Therapeutics, Inc.'s patent record in context - here's where to go next.
- Lpoxy Therapeutics, Inc.'s lead technology class is C12Y (Enzymes), 100% of its portfolio - see every assignee active in that class. Explore C12Y
- Ranked #29,324 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Lpoxy Therapeutics, Inc. against Loesch Verpackungstechnik GMBH + Co. KG, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 46.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.